MedTrace Logo

Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects

NCT01399749 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-07-22

No results posted yet for this study

Summary

The objective of our study is to compare the safety and effectiveness of the use of autologous cultured adipose tissue-derived stem cells versus cultured autologous chondrocytes for the treatment of chondral knee lesions.

Conditions

  • Articular Cartilage Lesion of the Femoral Condyle

Interventions

OTHER

Implantation of autologous cells

Implantation of autologous ASC or chondrocytes, 1 million per cm² lesion, covered by autologous periosteal membrane

Sponsors & Collaborators

  • Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz

    lead OTHER

Principal Investigators

  • Alonso C. Moreno Garcia, MD · Orthopedic Surgery and Traumatology Department. Knee Unit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01399749 on ClinicalTrials.gov